Neuren Pharmaceuticals Limited (ASX:NEU) has lodged an initial director's interest notice disclosing that Zita Peach was appointed to the company's board on 12 November 2026, holding no securities in the company at the time of appointment.

Key Points

  • Zita Peach was appointed as a director of Neuren Pharmaceuticals Limited effective 12 November 2026.
  • Peach holds nil securities in Neuren Pharmaceuticals as a registered holder at the time of appointment.
  • Peach holds no relevant interests in Neuren Pharmaceuticals securities as a non-registered holder.
  • No interests in contracts were disclosed in the initial director's interest notice.

Appointment of Zita Peach to Neuren Pharmaceuticals Board

Neuren Pharmaceuticals Limited, registered with ABN 72 111 496 130, disclosed the appointment of Zita Peach as a director, with the appointment date recorded as 12 November 2026. The disclosure was made in accordance with ASX listing rule 3.19A.1 and for the purposes of section 205G of the Corporations Act. The filing was submitted as an Appendix 3X initial director's interest notice, which is required when a new director joins a listed entity and must disclose their relevant interests in the company's securities at the time of appointment.

Securities Holdings Disclosed at Time of Appointment

According to the filing, Zita Peach holds nil securities in Neuren Pharmaceuticals as a registered holder at the date of her appointment. The notice also confirmed that Peach holds no relevant interests in securities of which she is not the registered holder, including interests held through trusts or other arrangements. The filing states that no details of any holder name, nature of interest, or number and class of securities apply to Part 2 of the notice, with the relevant fields recorded as nil.

No Contracts or Additional Interests Declared

The initial director's interest notice discloses that Zita Peach has no interests in contracts to report under Part 3 of the Appendix 3X form. No details of contract, nature of interest, name of registered holder, or number and class of securities to which any interest relates were provided, as no such interests exist at the time of appointment. The filing confirms the absence of any notifiable interest falling within the relevant provisions of the Corporations Act applicable to incoming directors of ASX-listed entities.